IN BRIEF: Eco Animal Gets US Marketing Authorisation For Aivlosin

ECO Animal Health Group PLC - pet and livestock pharmaceuticals company headquartered in Surrey - ...

Alliance News 13 January, 2021 | 12:02PM
Email Form Facebook Twitter LinkedIn RSS

ECO Animal Health Group PLC - pet and livestock pharmaceuticals company headquartered in Surrey - Receives marketing authorisations from the US Center for Veterinary Medicine of the Food & Drug Administration and from the Veterinary Drugs Directorate of Health Canada for swine respiratory disease medicine Aivlosin. The medicine will be marketed through Eco Animal's sales and marketing joint operation with Pharmgate Corp, Pharmgate Animal Health.

"We are delighted to receive this significant marketing authorisation for Aivlosin Water Soluble Granules in the US and in Canada which are among the most important pork producing and exporting countries in the world. M. hyopneumoniae plays a pivotal role in the important swine respiratory disease segment and its control is frequently considered by swine producers to be one of the most important issues they face today," says Eco Animal Chief Executive Marc Loomes.

Current stock price: 255.00 pence

Year-to-date change: flat

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Eco Animal Health Group PLC 127.99 GBX 0.78 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures